Jump to any asset
849 assets, updated daily
As of September 27, 2026, The Bank of New York Mellon Corporation (BK) trades at $150.15. CleaRank Financial AI rates it Hold with a fair value of $144.50, 3.8% below the current price. Wall Street's consensus target is $144.50 across 16 analysts. RSI at 9 is in oversold territory, and the price is below its 50-day average of $158.71.
Bank of New York Mellon Corp-The (BK)
Bank of New York Mellon Corp-The NYSE
$150.15
-0.0400 (-0.03%)
At close: Sep 25, 4:00 PM EDT
AI Analyst Consensus
59 / 100
Bank of New York Mellon Corp (BK) is currently trading at $150.15, below its 50-day Simple Moving Average (SMA) of $158.71 but above its 200-day SMA of $136.06. The stock's Relative Strength Index (RSI) is at a low 9.4, indicating oversold conditions that could precede a rebound. Wall Street analysts maintain a 'Hold' consensus with a median price target of $144.50, which is below the current trading price, suggesting limited upside from current levels. Fundamentally, BK exhibits a profit margin of 28.72% and an operating margin of 37.65%, with a return on equity of 13.47%. Its price-to-sales ratio stands at 4.54, which is slightly above the sector average of 3.8. The company's debt-to-equity ratio is a very low 0.02, indicating a strong balance sheet. Revenue growth has been reported at 13.4%, exceeding the sector average of 11.7%. Despite these solid fundamentals, the recent moderate insider selling and the median analyst target price below current levels present near-term headwinds.
BK Price Analysis
Market Metrics
Open
$150.45
Day Range
$148.51 to $151.35
Prev Close
$150.19
Volume
3.65M
52-Week Range
$103.11 to $165.84
Market Cap
$103.09B
Peer Benchmarking
Valuation vs Sector (Financial Services)
Performance vs IAI
Sector Position Analysis
Valuation is broadly in line with sector peers (3% difference), suggesting fair market pricing relative to industry standards.
BK Financial Performance
Revenue vs. Earnings
Annual
Quarterly
Earnings Reality Check
Analysis: In the last 5 quarters, BK beat estimates 5 times. The stock rose 4 times the next day. Price tends to react positively to beats.
BK Analysis
Company's Health
4/5
12-Month Analyst Target
-3.76% Downside
Median of 16 analysts (12-month)
$144.50
AI Technical Analysis
Bank of New York Mellon Corp (BK) is currently trading with bearish momentum, indicated by its RSI value of 9.4, which is considered oversold. The stock is positioned below its 50-day SMA ($158.71) and its 20-day EMA ($155.64), suggesting a near-term downtrend. However, it remains above its 200-day SMA ($136.06), which could act as a support level. The MACD is at -2.63, signaling downward momentum. Volume on the latest trading day was 3.65 million, which is below the average of 4.68 million, indicating less conviction behind the recent price action. Key support is seen at the 200-day SMA, while resistance lies at the 50-day SMA and the current price level.
ProTips
- Consider the moderate insider selling as a signal to approach with caution, despite the oversold technical conditions.
- The stock's position below its 50-day SMA and the median analyst target price being below the current level suggest that significant near-term upside may be limited.
- With a dividend yield of approximately 1.41%, investors seeking income should compare this to other opportunities in the diversified banking sector.
Key Catalysts
Bearish
Moderate Insider Selling Pressure
Insiders have sold $16.4 million worth of stock with no reported purchases, indicating a lack of immediate confidence from management and potentially signaling headwinds.
Source: Insider Trading DataBearish
Analyst Price Targets Below Current Price
The median analyst price target for BK is $144.50, which is below the current trading price of $150.15, suggesting limited upside potential according to Wall Street analysts.
Source: Wall Street ConsensusBullish
Oversold RSI Suggests Potential Rebound
The stock's RSI is at 9.4, indicating significantly oversold conditions which historically can precede a short-term price bounce or reversal.
Source: Technical AnalysisBullish
Consistent Earnings Beats
Bank of New York Mellon Corp has a track record of exceeding earnings per share estimates, most recently with a 6.67% beat in the quarter to March 2026 and a significant 93.4% beat in the quarter to December 2025.
Source: Earnings ReportsMarket Outlook
The base case outlook for Bank of New York Mellon Corp (BK) suggests a potential stabilization and modest recovery from current oversold levels, supported by its strong balance sheet and consistent earnings beats. The company's revenue growth is projected to be around 5.00% next quarter and 7.00% for the current year, with a healthy 5-year average annual growth estimate of 14.5%. The median analyst target price of $144.50, however, implies limited upside from the current $150.15 price. Key catalysts for upside could include a broader market recovery or positive shifts in interest rate policy benefiting financial institutions. Conversely, persistent insider selling and the fact that the current price exceeds the median analyst target price represent significant downside risks. Any failure to capitalize on the oversold technical conditions could lead to further price declines, potentially testing the 200-day SMA support at $136.06.
Key Statistics
| Market Cap | 103.09B |
|---|---|
| P/E Ratio | 17.02 |
| EPS (TTM) | 8.06 |
| Dividend Yield | 1.41% |
| 52 Week High | 165.84 |
| 52 Week Low | 103.11 |
Bank of New York Mellon Corp (BK) presents a mixed valuation picture, with a P/E ratio of 17.02 and a price-to-sales ratio of 4.54, which is slightly above the sector median of 3.8. Its return on equity stands at 13.47%, closely matching the sector average of 13.8%, and its profit margin of 28.72% is strong. The company's debt-to-equity ratio is an exceptionally low 0.02, indicating minimal financial leverage and a strong balance sheet. Revenue growth of 13.4% outpaces the sector average of 11.7%, suggesting healthy top-line expansion. Despite these positive fundamental indicators, the current price-to-sales ratio and P/E ratio suggest the stock is not significantly undervalued relative to its peers. The company's strong profitability and growth, coupled with its low debt, provide a solid foundation, but the current valuation metrics do not signal a significant discount.
Earnings & Growth Analysis
Bank of New York Mellon Corp (BK) has demonstrated a pattern of beating earnings estimates in recent quarters. For the quarter to March 2026, the company reported an EPS of $2.72, surpassing the estimate of $2.55 by 6.67%, though the stock saw a 2.21% decline. In the quarter to December 2025, BK delivered an EPS of $6.15 against an estimate of $3.18, a substantial 93.4% surprise, which was followed by a 2.65% stock price increase. This consistent ability to exceed expectations suggests operational efficiency and effective management.
Key Risks
A primary risk for Bank of New York Mellon Corp (BK) is the moderate insider selling, with total sales amounting to $16.4 million against no reported purchases, signaling a potential lack of immediate conviction from management. Also, the median analyst price target of $144.50 is below the current stock price of $150.15, indicating limited upside potential according to Wall Street expectations. The stock's oversold RSI of 9.4, while suggesting a potential bounce, also reflects recent negative price momentum that could persist.
Technical Indicators
| RSI (14) | 9.40 |
|---|---|
| MACD | -2.63 |
| SMA 50 | 158.71 |
| SMA 200 | 136.06 |
RSI
Oversold
SMA Cross
Bullish
Price vs SMA
Bearish
MACD
Bearish
Golden Cross in effect with the 50-day SMA ($158.71) above the 200-day SMA ($136.06), price is trading below the 50-day SMA, RSI at 9.4 suggests oversold conditions; potential bounce setup.
Market Correlations
How this stock moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
S&P 500 (SPY)
+0.62
Moderate correlation
Nasdaq 100 (QQQ)
+0.52
Moderate correlation
Bitcoin (BTC)
+0.27
Weak correlation
Gold (XAU)
+0.13
Weak correlation
Check Custom Correlation
How does any other asset move with BK? One year of daily closes, Pearson correlation.
Try
BK Trade Plans
Specific entry, exit, and risk management levels
Select Your Trade Bias
Risk Tolerance
Conservative
2%
Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →
Entry Strategies pick an entry style
Conservative
$148.65
Slight discount to current
Wait for small dip
Aggressive
$150.15
At current price
Enter now if confident
Risk Management
STOP LOSS
$143.74
MAX LOSS
-3.3%
Volatility-Adjusted Stop Loss
Calculated based on RSI (9.4) and current market volatility
Profit Targets (Based on Conservative Entry)
TARGET 1
$153.11
+3% (Conservative)
+2.0% (Aggressive)
TARGET 2
$156.08
+5% (Conservative)
+4.0% (Aggressive)
TARGET 3
$160.54
+8% (Conservative)
+6.9% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
Calculate Your Trade
Disclaimer
This AI-generated trade plan for BK is for educational and informational purposes only and does not constitute financial advice. The analysis is based on historical data patterns and technical indicators which may not predict future results. Stock trading involves risk of loss. Verify all data independently and consult a qualified financial advisor. Generated on September 27, 2026.Growth of $10,000
A $10,000 investment in BK in September 2016 would be worth about $38,013 today, compared with about $35,782 for the same investment in the S&P 500 benchmark.
Compare with Another Ticker
Monte Carlo Projection (10yr)
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in BK today could grow to about $27,377 by 2036 in the base case, with a bull case near $81,769 and a bear case around $9,166. Projections are statistical simulations, not guarantees.
BK Stock Price Prediction: 2030
CleaRank's simulation projects a price near $225 for BK by 2030 in the base case, from $150 today (1.5x over 4 years). The downside path ends near $112. These are outcomes of a Monte Carlo simulation run on BK's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | Downside (10th pct) | Base case | Upside (90th pct) |
|---|---|---|---|
| 2027 | $117 | $166 | $235 |
| 2028 | $113 | $184 | $300 |
| 2029 | $112 | $203 | $370 |
| 2030 | $112 | $225 | $449 |
| 2031 | $115 | $248 | $539 |
| 2032 | $118 | $275 | $641 |
| 2033 | $122 | $304 | $759 |
| 2034 | $126 | $336 | $894 |
| 2035 | $132 | $372 | $1,050 |
| 2036 | $138 | $411 | $1,228 |
Method: 10,000 simulated price paths using BK's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.
People Also Watch
BK Insider Trading Analysis
Bought
None
No open-market buys
Sold
$16.4M
8 Transactions
Insiders
15
Active Traders
Avg Transaction
$2.1M
Large trades
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jan 28, 2019 | GARDEN EDWARD P
Director
|
Sell | 2.1M | $112.7M |
| Mar 13, 2019 | GARDEN EDWARD P
Director
|
Sell | 792.0K | $41.3M |
| May 3, 2019 | GARDEN EDWARD P
Director
|
Sell | 621.8K | $31.2M |
| Apr 8, 2020 | BERKSHIRE HATHAWAY INC
Beneficial Owner of more than 10% of a Class of Security
|
Sell | 869.1K | $30.9M |
| Jul 24, 2019 | GIBBONS THOMAS P
Officer
|
Sell | 318.6K | $14.9M |
| Aug 8, 2022 | GIBBONS THOMAS P
Chief Executive Officer
|
Sell | 239.1K | $10.3M |
| May 12, 2021 | GIBBONS THOMAS P
Chief Executive Officer
|
Sell | 155.9K | $8.0M |
| Apr 14, 2025 | KEATING CATHERINE
Officer
|
Sell | 65.5K | $5.1M |
| Apr 17, 2026 | MCCARTHY JOHN KEVIN
General Counsel
|
Sell | 30.0K | $4.1M |
| Apr 18, 2024 | KEATING CATHERINE
Officer
|
Sell | 54.1K | $3.0M |
Page 1 of 1
Frequently Asked Questions
What is Bank of New York Mellon Corp's stock price forecast for 2030?
Based on Monte Carlo simulations, Bank of New York Mellon Corp's stock price is projected to be $224.64 in 2030 under base case assumptions. The downside projection is $112.44, and the upside projection is $448.77. These are statistical outcomes, not guarantees.
Is Bank of New York Mellon Corp stock a buy right now?
The current consensus rating for Bank of New York Mellon Corp is 'Hold'. While the stock is trading at an oversold RSI at 9.4, suggesting a potential bounce, the median analyst target price of $144.50 is below the current price of $150.15, and there has been moderate insider selling.
What are the key technical indicators for Bank of New York Mellon Corp?
Bank of New York Mellon Corp's technical indicators show bearish momentum with an oversold RSI at 9.4 and a MACD of -2.63. The stock is trading below its 50-day SMA ($158.71) and 20-day EMA ($155.64), but remains above its 200-day SMA ($136.06).
How does Bank of New York Mellon Corp's financial health compare to its peers?
Bank of New York Mellon Corp exhibits strong financial health with a very low debt-to-equity ratio of 0.02, significantly below the sector average. Its profit margin of 28.72% and return on equity of 13.47% are competitive within the Financial Services sector.
What is the analyst consensus for Bank of New York Mellon Corp?
The Wall Street consensus for Bank of New York Mellon Corp is 'Hold', with 16 analysts covering the stock. The breakdown includes 3 Strong Buys, 6 Buys, 6 Holds, and 1 Strong Sell, resulting in a consensus score of 59 out of 100.
Are insiders buying or selling Bank of New York Mellon Corp stock?
Insiders are net sellers of Bank of New York Mellon Corp stock, with total sales of $16.4 million and no reported purchases. This moderate sell signal suggests caution among management regarding the stock's near-term prospects.
What is the revenue growth outlook for Bank of New York Mellon Corp?
Bank of New York Mellon Corp is expected to see continued revenue growth, with estimates projecting a 5.00% increase for the next quarter and 7.00% for the current year. The long-term outlook remains positive, with an estimated 5-year average annual growth rate of 14.5%.